Immuneering Corporation (IMRX) Misses Q4 EPS by 13c

Immuneering Corporation (NASDAQ: IMRX) reported Q4 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• Health In Tech (HIT) files for 29.53M share offering by selling stockolders
• Lynx Equity sees Micron and SanDisk breakout as volatility normalizes